Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
A new experimental study by Nyack Hospital's Clinical Pharmacy Manager finds racial differences in the optimal dosing of the antibiotic doripenem in critically ill patients. The study, led by Andras Farkas, PharmD., suggests the need for more aggressive dosing of the drug in patients of Hispanic descent.
The findings will be presented at the Infectious Disease Society of America Annual Meeting, held in San Francisco from October 2-6, 2013, by Nyack infectious disease specialist Dr. Kenneth Rowin.
Doripenem (Doribax) is used as a last line of therapy against the most resistant organisms, Dr. Farkas says. The drug, used frequently at Nyack Hospital, is given to treat serious infections of the urinary tract, kidney, and abdomen that are often caused by multi-drug resistant bacteria.
The drug is administered intravenously, and is cleared through the kidneys before the body eliminates it. A study published in 2010, which provided the basis of this experiment at Nyack Hospital, suggested there might be racial differences in how quickly the drug was cleared. "This is very important, because the clearance rate affects the concentration of the drug in the blood," he says. "We want to maintain a certain concentration in the blood, and if you have a faster clearance, concentrations are lower than the body needs."
As a result of his findings, Dr. Farkas recommends that if patients of Hispanic descent don't respond to the dose of doripenem they are given, doctors should consider a different dosing strategy, such as extending the infusion time or increasing the dose, depending on the organism being treated.
It is not known why Hispanics clear doripenem out of their system faster than people of other groups, Dr. Farkas noted.
Article adapted by Medical News Today from original press release. Source:
Please use one of the following formats to cite this article in your essay, paper or report:
Hospital, Nyack. "Nyack Hospital experimental study finds racial differences in optimal dosing of antibiotic used for critically ill patients." Medical News Today. MediLexicon, Intl., 30 Aug. 2013. Web.
13 Dec. 2013. <http://www.medicalnewstoday.com/releases/265409>
Hospital, N. (2013, August 30). "Nyack Hospital experimental study finds racial differences in optimal dosing of antibiotic used for critically ill patients." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/265409.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.